Hint mode is switched on Switch off

Bluebird Bio, ordinary share
BLUE, US09609G1004

Add a stock to WL
Choose all Reset all
Bluebird Bio, сountry — USA
16/12/2024 stock stopped trading due to affiliation to Bluebird Bio, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Bluebird Bio, Inc. operates as a clinical-stage biotechnology company that develops potentially transformative gene therapies for severe genetic diseases and cancer.
  • Issuer
  • Full borrower / issuer name
    Bluebird bio, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLUE
  • Placement
    19.06.2013
  • Lock up period
    180
  • Number of papers
    5,941,176
  • Volume of raised funds
    101 mln USD
  • Final placement price
    17 USD
  • Price change since placement date
    -100%
  • By capitalization
    371.78 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLUE
  • Placement
    28.06.2017
  • Lock up period
    180
  • Number of papers
    3,810,000
  • Volume of raised funds
    400.05 mln USD
  • Placement share
    8.52%
  • Final placement price
    105 USD
  • Price change since placement date
    -100%
  • By capitalization
    4,696.93 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BLUE
  • Placement
    20.12.2023
  • Lock up period
    180
  • Number of papers
    190,355,471
  • Volume of raised funds
    125 mln USD
  • Placement share
    43.78%
  • Final placement price
    1.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    285.53 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

02/06/2025 Bluebird Bio: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
28/03/2025 Bluebird Bio: Other Events, Financial Statements And Exhibits
21/02/2025 Bluebird Bio: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
13/12/2024 bluebird bio, Inc. (NASDAQ: BLUE) Implements Reverse Stock Split
12/12/2024 Bluebird Bio: Amendment To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.